Indeed, this could be a good antidiabetic strategy because GSK3-β is a capital substrate of the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling involved regulating glycogen synthesis, and GS plays an important role in insulin resistance [101]. The gene discussed is AKT1; the disease is Insulin resistance.